Our patents

Thioredoxin Systems AB has a broad patent protection covering both composition of matter and medical use/treatment. Our patent strategy is global, and protected markets are considered clinically and commercially relevant for our products.

Granted or pending patents marked dark blue.

Patent family Patent/application no. Granted patents Pending patents Expiry
Composition comprising selenazol or thiazolone derivates and metal ions and method of treatment therewith US 10,058,542
US 16/113,847
US 2036
Method of treatment of Helicobacter Pylori infection using PZ25 (ebsulfur) US 8,592,468 US 2027
Antibiotic compositions comprising silver and selenium WO 2018/104777 US Australia, Brazil, Canada, Europe, Japan, South Korea 2037